Search results for

New Yorkers spent part of this fall pedaling demo versions of a new bike that may become as common as the city's yellow cabs. The city has chosen an Oregon company to set up a fleet of 10,000 rental bikes.

A Frankfurt stock trader who lost his job in the 2008 recession is working again in the city's financial district — running a successful business selling sausages to his former colleagues. Thomas Brausse says getting the pink slip enabled him to try out an idea he'd been thinking about for years.

Melissa Block talks to Gabriel Feldman, director of the Tulane University sports law program, about the latest news on the NBA lockout. NBA players rejected a deal from the league's owners, and they're beginning to disband their union. This year's season may be in jeopardy.

While the economy has dominated the presidential race, a Republican debate this weekend put the focus on foreign affairs. The GOP presidential candidates tried to draw sharp contrasts with Obama, criticizing his handling of Iran, China and suspected terrorists.

The decision means the Obama administration no longer has to make a tough decision on whether to allow the oil pipeline to pass through an environmentally sensitive aquifer.

Meanwhile, wholesale prices dipped thanks to a sharp drop in energy costs.

There's a lot going wrong and not much in the way of positive news to look forward to, say David Wessel of The Wall Street Journal and Zanny Minton Beddoes of The Economist.

A German designer's recipe: Take sour, organic milk; extract the protein casein; heat it; mix it with a few other ingredients; spin everything into threads. The result: fabric that feels like silk.

George and Ira Gershwin wrote some of their best songs for movies — one of which, 1937's A Damsel in Distress, has just been issued by Warner Archives. Critic Lloyd Schwartz says it may be the oddest of the Gershwin brothers' films.

A survey finds 42 percent of hospitals offer at least one type of complementary or alternative medicine treatment. Those hospitals that offer the options cite patient demand as the top reason. Clinical effectiveness is the No. 2 reason.